ArticleBone marrow transplantation2026

Feasibility of outpatient administration of ciltacabtagene autoleucel and reduction in healthcare utilization cost: the Vanderbilt experience.

Ihunayachi Ohuabunwa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.